About the speaker: Susana has been with Ypsomed for 5 years. She began her career in the pharma industry where she spent over 16 years with the company Geistlich Pharma. She spent over 5 years volunteering for the Regulatory Affairs Professionals Society (RAPS) where she was most recently the Chair for the European Council.

About the company: Ypsomed is a Swiss company founded in 1984, and was originally named Disetronic. They are a leading developer and manufacturer of injection and infusion systems. Their product portfolio includes injection pens, autoinjectors, and infusion systems for the self-administration of liquid medications. Their products are used for people with diabetes, multiple sclerosis, rheumatoid arthritis and cancer. They manufacture products globally, including Switzerland, Germany, The US, China and Japan, and their products are sold in over 70 countries.

Revenue: 552 million USD

Employees: >2,000